glp 1 agonist mechanism of action weight loss GLP-1 Agonists - What is it? Resmetirom and GLP-1 agonists for

These formulas can be used together or on their own to support natural healthy weight loss without the high price tag and dangerous side effects

Diabetes Care 48(1):S207-38 Marx N, Federici M, Schtt K, Mller-Wieland D, Ajjan RA, Antunes MJ et al (2023) 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)

Other AEs reported with SGLT2i use include osmotic diuresis-related events and volume depletion-related hypotension, the latter of which tends to be more common in older adults, people with an eGFR of 3060 mL/min/1.73 m 2 , and in those taking loop diuretics [4]

Market perspective Fast-track approval reflects urgency in tackling obesity Oral therapies may capture ~20% of the market by 2030 Expands access for patients preferring pills over injections While Novo Nordisk may offer slightly higher weight loss with its oral option, ease of use and flexibility position this therapy as a strong competitor

Long term, however, weight loss and GLP-1s may reduce flare frequency

Assessment and Categorisation of Cardiovascular Risk in Diabetes Various definitions of CV risk have been proposed in multiple guidelines